Review article · 2022 · Open access
Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
Pharmaceutics, 14(10), 2033 · Published 24 September 2022 · DOI 10.3390/pharmaceutics14102033
In brief
“Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy” is a 2022 review article by Wanting Hou and 2 co-authors, published in Pharmaceutics. OpenAlex counts 27 citations as of 21 November 2026, which puts it in the top 5% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.
- Citations
- 27
- Most cited in
- 2025 (13)
- Field-weighted impact
- 0.31
- References
- 148
- Authors
- 3
Abstract
Immunotherapy has dramatically changed prognosis for patients with malignant tumors. However, as a non-immunogenic tumor, pancreatic ductal adenocarcinoma (PDAC) has a low response to immunotherapy. Factors that contribute to the inefficiency of PDAC immunotherapy include the tumor microenvironment (TME) and its dense stroma, which acts as a barrier for drug delivery and immune cell infiltration. Recent studies have shown that nanoparticle-based therapeutic strategies have more promising applications in improving drug delivery and reversing the immunosuppressive TME for PDAC. Therefore, nanomaterial-based therapeutic approaches are expected to enhance the effectiveness of immunotherapy and improve prognosis of patients with PDAC. Here, we outline the status and dilemma of PDAC immunotherapy, and summarize the latest advances in nanoparticle-based treatment strategies to enhance the efficacy of PDAC immunotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hou, W., Yang, B., & Zhu, H. (2022). Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy. Pharmaceutics, 14(10), 2033. https://doi.org/10.3390/pharmaceutics14102033
MLA 9
Hou, Wanting, et al. “Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.” Pharmaceutics, vol. 14, no. 10, 2022, p. 2033. https://doi.org/10.3390/pharmaceutics14102033.
Chicago
Hou, Wanting, Biao Yang, and Hong Zhu. 2022. “Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.” Pharmaceutics 14 (10): 2033. https://doi.org/10.3390/pharmaceutics14102033.
Harvard
Hou, W., Yang, B. and Zhu, H. (2022) ‘Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy’, Pharmaceutics, 14(10), p. 2033. doi:10.3390/pharmaceutics14102033.
IEEE
W. Hou, B. Yang, and H. Zhu, “Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy,” Pharmaceutics, vol. 14, no. 10, p. 2033, 2022, doi: 10.3390/pharmaceutics14102033.
BibTeX
@article{hou2022nanoparticle,
title = {{Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy}},
author = {Hou, Wanting and Yang, Biao and Zhu, Hong},
journal = {Pharmaceutics},
year = {2022},
volume = {14},
number = {10},
pages = {2033},
doi = {10.3390/pharmaceutics14102033},
url = {https://doi.org/10.3390/pharmaceutics14102033}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 4 | |
| 2024 | 3 | |
| 2025 | 13 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.31: it has been cited 0.31 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic ductal adenocarcinoma
- cancer immunotherapy
- nanoparticles
- tumor microenvironment
- tumor stroma
- immunosuppression
- drug delivery
- nanomaterials
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Hou, W., Yang, B., & Zhu, H. (2022). Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy. Pharmaceutics, 14(10), 2033. https://doi.org/10.3390/pharmaceutics14102033
How many times has this paper been cited?
27 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.
Who wrote this paper?
Wanting Hou, Biao Yang, Hong Zhu.
What is the DOI of this paper?
10.3390/pharmaceutics14102033, permanently at https://doi.org/10.3390/pharmaceutics14102033. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.